As GLP-1s transform obesity care, many hope to “get off” treatment—but real-world data shows stopping early leads to weight regain and worse health outcomes. Obesity is a chronic disease. Ongoing treatment isn’t failure—it’s care. Let’s stop chasing the off-ramp and start building support to stay on.

While headlines focus on how Ozempic is reshaping economies, I can’t stop thinking about how it’s reshaping lives. At nymble, we hear directly from people navigating GLP-1s — the confusion, emotional shifts, and social changes. These medications aren’t shortcuts. They’re a starting line — and real support is needed to walk the path beyond them.

The nymble platform is app-free by design. You don’t need to sign up, download, or log in. You don’t need to update anything. nymble is simply a contact on your phone. You send a message, and it responds. That’s it.